Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy

Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy

The use of PD-1 immune checkpoint inhibitor medications has become a common practice in the treatment of recurrent and metastatic head and neck squamous-cell carcinomas. Success in this setting has led to the investigation of their efficacy in locally advanced cases as a part of first-line therapy....

Full description

Bibliographic Details
Main Authors: Natalia Trehan, Angelina Debbas, Mykaihla Sternick, Jennifer Johnson, James C. Gates
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Current Oncology
Subjects:
immunotherapy
palliative intent
squamous-cell carcinomas
head and neck squamous-cell carcinomas
Online Access:https://www.mdpi.com/1718-7729/30/12/767

Similar Items

Similar Items